CIBC World Markets Inc. Purchases Shares of 34,243 Walgreens Boots Alliance, Inc. (WBA)

CIBC World Markets Inc. bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 34,243 shares of the pharmacy operator’s stock, valued at approximately $2,682,000.

Other large investors have also bought and sold shares of the company. RB Capital Management LLC boosted its position in shares of Walgreens Boots Alliance by 25.8% in the first quarter. RB Capital Management LLC now owns 3,969 shares of the pharmacy operator’s stock worth $330,000 after acquiring an additional 813 shares during the last quarter. Karp Capital Management Corp acquired a new position in Walgreens Boots Alliance during the first quarter valued at approximately $30,227,000. First Foundation Advisors raised its stake in shares of Walgreens Boots Alliance by 40.2% during the first quarter. First Foundation Advisors now owns 21,037 shares of the pharmacy operator’s stock valued at $1,747,000 after purchasing an additional 6,032 shares during the period. FormulaFolio Investments LLC purchased a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $292,000. Finally, Parkwood LLC raised its stake in shares of Walgreens Boots Alliance by 62.6% during the first quarter. Parkwood LLC now owns 40,735 shares of the pharmacy operator’s stock valued at $3,383,000 after purchasing an additional 15,690 shares during the period. Hedge funds and other institutional investors own 63.58% of the company’s stock.

In other Walgreens Boots Alliance news, Director John Anthony Lederer bought 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 13.50% of the stock is currently owned by insiders.

WARNING: This piece of content was first reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.truebluetribune.com/2017/11/14/cibc-world-markets-inc-takes-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $70.37 on Tuesday. The company has a market capitalization of $71,667.88, a P/E ratio of 13.92, a PEG ratio of 1.26 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a one year low of $63.82 and a one year high of $88.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.07 EPS. research analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.27%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.

Walgreens Boots Alliance announced that its Board of Directors has approved a share buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

WBA has been the subject of a number of research analyst reports. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday. Citigroup Inc. lowered their target price on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, November 2nd. Leerink Swann downgraded shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Monday, October 30th. Finally, Jefferies Group LLC set a $93.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday, October 29th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $87.63.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply